CARD9

Chr 9AR

caspase recruitment domain family member 9

Also known as: CANDF2, IMD103, hCARD9

The CARD9 protein functions as an adapter protein that forms signaling complexes downstream of C-type lectin receptors, playing a key role in innate immune response against fungi by activating NF-kappa-B and MAP kinase pathways. Biallelic mutations cause autosomal recessive immunodeficiency with susceptibility to fungal infections, particularly affecting the ability to mount effective antifungal immunity against certain fungi from the phylum Ascomycota. This gene is not highly constrained against loss-of-function variation (pLI near zero), consistent with its recessive inheritance pattern where heterozygous carriers are typically unaffected.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 1.131 OMIM phenotype
Clinical SummaryCARD9
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.13LOEUF
pLI 0.000
Z-score 1.04
OE 0.79 (0.561.13)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.10Z-score
OE missense 0.99 (0.901.08)
355 obs / 360.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.79 (0.561.13)
00.351.4
Missense OE0.99 (0.901.08)
00.61.4
Synonymous OE1.16
01.21.6
LoF obs/exp: 22 / 27.9Missense obs/exp: 355 / 360.3Syn Z: -1.56
DN
0.6358th %ile
GOF
0.6640th %ile
LOF
0.3745th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CARD9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗